Company News for Dec 8, 2023

  • Ciena Corporation (CIEN) shares rose 1.2% after the company reported fourth-quarter earnings of 75 cents per share, beating the Zacks Consensus Estimate of 68 cents.
     
  • Merck & Co., Inc. (MRK) shares fell 1.7% due to the failure of its immunotherapy combination in a lung cancer study.
     
  • Verint Systems Inc. (VRNT) shares jumped 19% after the company reported third-quarter revenues of $218.5 million, outpacing the Zacks Consensus Estimate of $216.3 million.
     
  • Shares of Oxford Industries, Inc. (OXM) gained 3.9% after the company reported third-quarter 2023 revenues of $326.63 million, surpassing the Zacks Consensus Estimate of $325.7 million.
     

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Merck & Co., Inc. (MRK) : Free Stock Analysis Report

Ciena Corporation (CIEN) : Free Stock Analysis Report

Oxford Industries, Inc. (OXM) : Free Stock Analysis Report

Verint Systems Inc. (VRNT) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Zacks
Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.
More articles by this source
Stocks Mentioned

Latest Articles

Data is currently not available